Mirae Asset Global Investments Co., Ltd. Zynerba Pharmaceuticals, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$22.5 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.87 - $1.36 $287,640 - $449,644	-330,621 Reduced 26.83%	901,835 $660,000
Q2 2022 Jul 26, 2022	SELL	$0.86 - $2.06 $10,995 - $26,337	-12,785 Reduced 1.03%	1,232,456 $1.41 Million
Q1 2022 May 10, 2022	SELL	$1.83 - $3.02 $225,452 - $372,057	-123,198 Reduced 9.0%	1,245,241 $2.55 Million
Q4 2021 Feb 08, 2022	BUY	$2.88 - $4.3 $41,788 - $62,393	14,510 Added 1.07%	1,368,439 $3.94 Million
Q3 2021 Nov 15, 2021	SELL	$3.72 - $5.35 $1.06 Million - $1.52 Million	-284,471 Reduced 17.36%	1,353,929 $5.74 Million
Q2 2021 Aug 11, 2021	BUY	$3.83 - $5.98 $5.15 Million - $8.04 Million	1,344,559 Added 457.58%	1,638,400 $8.67 Million
Q1 2021 May 13, 2021	SELL	$3.33 - $8.76 $1.19 Million - $3.12 Million	-356,040 Reduced 54.79%	293,841 $1.37 Million
Q4 2020 Feb 10, 2021	BUY	$3.27 - $4.64 $793,377 - $1.13 Million	242,623 Added 59.57%	649,881 $2.15 Million
Q3 2020 Nov 12, 2020	BUY	$3.23 - $4.3 $175,925 - $234,203	54,466 Added 15.44%	407,258 $1.35 Million
Q2 2020 Aug 11, 2020	BUY	$3.31 - $6.54 $128,974 - $254,831	38,965 Added 12.42%	352,792 $1.19 Million
Q1 2020 May 12, 2020	BUY	$2.9 - $6.16 $31,992 - $67,957	11,032 Added 3.64%	313,827 $1.2 Million
Q4 2019 Feb 12, 2020	SELL	$5.61 - $8.57 $1.36 Million - $2.07 Million	-241,613 Reduced 44.38%	302,795 $1.83 Million
Q3 2019 Nov 12, 2019	BUY	$7.56 - $15.44 $1.06 Million - $2.16 Million	139,848 Added 34.57%	544,408 $4.12 Million
Q2 2019 Aug 13, 2019	BUY	$5.4 - $15.5 $2.18 Million - $6.27 Million	404,560 New	404,560 $5.48 Million
Q1 2018 May 10, 2018	SELL	$8.49 - $13.46 $3.07 Million - $4.86 Million	-361,062 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$8.69 - $14.59 $195,611 - $328,420	22,510 Added 6.65%	361,062 $4.52 Million
Q3 2017 Nov 08, 2017	BUY	$5.73 - $9.44 $203,082 - $334,572	35,442 Added 11.69%	338,552 $2.83 Million
Q2 2017 Aug 14, 2017	BUY	N/A	303,110	303,110 $5.14 Million

Others Institutions Holding ZYNE

# of Institutions

Shares Held

774K

Call Options Held

Put Options Held

View Full List

About Zynerba Pharmaceuticals, Inc.

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

More about ZYNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account